Results for tag: "Strattera"

Strattera is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). It is a selective norepinephrine reuptake inhibitor (SNRI) and is the only non-stimulant medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of ADHD. Strattera is used to improve focus, reduce impulsivity, and improve overall functioning in people with ADHD. It is also used to treat depression and anxiety in adults. The mental disorders drugs market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global mental disorders drugs market will reach $100 billion by 2025. The market is driven by the increasing prevalence of mental health disorders, the growing awareness of mental health issues, and the availability of new treatments. Companies in the Strattera market include Eli Lilly, Pfizer, Shire, Novartis, and Johnson & Johnson. Show Less Read more